SSTR4 is a promising candidate biomarker, as our study implicated its role in modulating cognitive processes and demonstrated alterations in SSTR4 expression and function in schizophrenia patients, correlating with cognitive deficits. The gene discussed is SSTR4; the disease is schizophrenia.